IONIS PHARMACEUT. DL-001 financial statements, including revenue, expenses, profit, and loss
The total revenue of ISI for the last quarter is 294.45 M EUR, and it's 115.85% higher compared to the previous quarter. The net income of Q4 23 is -8.15 M EUR.